Por que Participar
Neste momento inédito e incerto, devido ao aumento da contaminação por Covid-19, surge a urgente necessidade de maior colaboração e comunicação no setor de saúde animal. Parcerias estratégicas são fundamentais para oferecer as novas soluções necessárias ao "Novo normal" nessa indústria.
Na América Latina, a situação é dinâmica. A região é uma das mais importantes para a produção de proteína animal e o terceiro maior mercado de saúde animal do mundo. Como o desafio global de alimentar mais 2 bilhões de pessoas até 2050 continua sendo máxima prioridade, a América Latina ainda precisará aumentar seus volumes de produção anual em 70% e reduzir bastante a perda atual de animais por morte ou doença, índice atualmente estimado em mais de 20%.
Como o desafio global de alimentar mais 2 bilhões de pessoas até 2050 continua sendo máxima prioridade, a América Latina ainda precisará aumentar seus volumes de produção anual em 70% e reduzir bastante a perda atual de animais por morte ou doença, índice atualmente estimado em mais de 20%. A região também é o terceiro maior mercado do mundo para cuidados de animais domésticos, sendo que o Brasil abriga mais de 58 milhões de cães e 27 milhões de gatos. No Brasil, os donos de animais de estimação reservam um orçamento para seus animais e os tratam como membros da família. Isso faz parte de uma tendência global de humanização que está afetando significativamente a indústria e criando novas oportunidades de negócios, mesmo na crise.
Na Kisaco Research, temos o compromisso de oferecer à comunidade de saúde animal uma plataforma onde possamos nos reunir, continuar criando conexões estratégicas vitais e promovendo negócios via reuniões virtuais de parceria. Acreditamos que esta será uma nova experiência para muitos de vocês em todo o mundo, pois o trabalho remoto tornou-se o novo normal nos negócios, e esperamos trabalhar juntos para que essa experiência seja realmente eficaz.
Quem participa?
PALESTRANTES E COLABORADORES
Carlos Alberto Kuada
Matias de Juan
Klaus Hellmann
Flávia De Marco Almeida
Luiz Luccas
Delair Angelo Bolis
Luiz Xavier Royas
Marcio Waldman
Felipe Cunha
Felipe Diz
Mauricio Salvador
Flavia Reis
Kristin Bloink
Kristin Bloink manages all internal discovery efforts and all external technology evaluations and subsequent portfolio entries for R&D. She has 26 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private as well as the military sector. She joined Novartis Animal Health in 2007 and integrated into Elanco Animal Health in 2015.
Kleber Gomes
Byron Silva
PROFILE:
- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.
- Support for technical and regulatory affairs for new and existing business.
- Support for development of new businesses in Brazil for global players.
Maria Aparecida Melo Luspa, MSc.
Gustavo Osorio
Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.
During his tenure in Pfizer Animal Health, Gustavo held different position of increased responsibility. He worked as Technical Manager for Companion Animal being responsible for technical trainings for the team as well as speaker in different events. He was promoted to Sales Force Manager, working in a sales efficiency project while starting his incursion in marketing, this movement allowed him to move to the Marketing Manager position.
In 2006, Gustavo joined Bayer Animal Health as Marketing Manager for Companion Animals. During his 8 year tenure, he contributed to the evolution of the business unit by introducing new lines of products while managing the growth of the companion animals portfolio.
From 2014 to 2018, Gustavo was Influencer Marketing Manager for Eukanuba at Mars. This position allowed him to better understand the motivations and habits of pet owners as well as learn from the pet food industry and gain a new set of skills oriented at the commercial models applied in this segment.
Since 2018, Gustavo is the Commercial Manager for Mexico, Central America and the Caribbean at Dechra Brovel, the Mexican subsidiary of Dechra. He is focused on the transformation of the company structure from a family owned company to an international corporation, successfully launching specialized products such as Vetoryl and Zycortal while maintaining the growth of the generic products business. He is also developing and strengthening his team to address future challenges.
Kieran Gartlan
Angélica Patarroyo Vargas
Arthur Gabriel da Silva
Bruna Nunes Marsiglio Sarout
Carla Berl
Ricardo Nassar
Ricardo Nassar has graduated in Business Administration by FAAP, an important University in Brazil. He is one of the co-founder at Cobasi – o shopping do seu animal since 1885.
Together with his brothers, has created the concept of big pet shop in Brazil and has turned Cobasi into a reference in the Brazilian pet market. Cobasi is currently sales leader, with more 100 stores and e-commerce.
Eduardo Carlos de Gosztonyi Abecia
Clóvis De Oliveira
Carla Freitas
Parceiro de Destaque
Elanco
Website: www.elanco.com
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
Parceiros
MSD Animal Health
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com/ or connect with us on LinkedIn and Twitter.
IDEXX
Website: www.idexx.com
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry, and testing for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries.
Our purpose is to be a great company that creates exceptional long-term value for our customers, employees, and shareholders by enhancing the health and well-being of pets, people, and livestock.
For more information about IDEXX, visit: www.idexx.com
Zoetis
Website: www.zoetis.com
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
For more information, visit www.zoetis.com.
A Agenda
Você pode baixar nossa agenda aqui.
Basta preencher este formulário e enviaremos a você uma versão em PDF agora mesmo. Precisamos de algumas informações para saber para onde enviar o arquivo e como endereçar nosso e-mail a você.
Precisamos de algumas informações para saber para onde enviar o link e como endereçar nosso e-mail a você. Observe que um link para o PDF também ficará imediatamente disponível depois que este formulário for enviado.
Download the Agenda
Conselho Consultivo Global
Author:
Joachim Hasenmaier
Author:
Clinton Lewis
Author:
Linda Rhodes
Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.
Author:
Aaron Schacht
Author:
Dr. James Lloyd
Pacotes para a conferência
Está enviando sua equipe? Estão disponíveis descontos para grupos!
Aplicam-se apenas a taxas para as categorias mercado primário, provedor de serviços e indústria. Não se aplica a taxas para as categorias acadêmica ou "start-up"
Reservar uma equipe de mais de 3 indivíduos - Economize mais 10%
Reservar uma equipe de mais de 5 indivíduos - Economize mais 15%
Se você quiser inscrever uma equipe de três ou mais indivíduos, envie um e-mail para [email protected] para obter seu código de cupom de desconto antes de inscrever-se
OBSERVAÇÃO: não é possível combinar os descontos com o Preço de registro antecipado nem qualquer outro desconto ou oferta. Se você tiver dúvidas sobre sua inscrição, ligue para nós pelo telefone +44 (0)20 3696 2920
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Torne-se um patrocinador
A Kisaco Research fornece a tão necessária plataforma em que os executivos do setor podem desenvolver uma rede de contatos, conectar-se e aprender uns com os outros, além de conhecer possíveis parceiros do setor.
Longe da experiência típica de "apresentar", você, como patrocinador ou expositor, será posicionado como um parceiro do evento com foco nos benefícios de seus produtos e de sua marca, em vez de apenas um nome em uma lista de exposição.Contate nossa equipe para saber mais sobre cada pacote enviando um e-mail para [email protected] ou telefonando para +44 (0)20 3696 2920
Parcerias com a imprensa
Seja você uma associação, uma embaixada, um órgão ou publicação do setor, podemos oferecer uma parceria de marketing personalizada para atender às suas necessidades. Como um parceiro de mídia, podemos:
- Promover sua organização como um parceiro do evento em todos os materiais da conferência, incluindo site, brochura, e-mails e programa no local
- Oferecer a seus membros ou leitores um desconto na taxa de registro para a Animal Health Innovation América Latina
- Fornecer um passe gratuito de imprensa para participação
- Distribuir materiais promocionais na conferência
Se você for um jornalista registrado do setor ou um membro da imprensa e quiser agendar uma entrevista com um palestrante para discutir o evento, entre em contato pelo e-mail:
Jessica Parry
T: +44 (0)203 696 2920
E: [email protected]
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
